对基因疗法的前性方法计算建模 - - 关注病毒基因疗法的焦点
Mary P Choules1, Peter L Bonate2, Nakyo Heo1
1Early Development, New Technologies Group, Astellas, Northbrook, IL, USA.
Journal of pharmacokinetics and pharmacodynamics
|October 17, 2023
概括
基于模型的药物开发 (MIDD) 可以通过解决数据差距来改善基因治疗剂量选择. 本综述提出了对腺相关病毒 (AAV) 基因疗法的先进MIDD方法,以告知剂量有效性和剂量毒性关系.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
- 药物开发 药物开发
背景情况:
- 基因治疗剂量选择受到有限的剂量毒性和剂量有效性数据的挑战.
- 基于模型的药物开发 (MIDD) 是制药开发中的标准工具,但对于基因疗法来说还不成熟.
- 标准化MIDD对于其在基因治疗临床方案中的应用至关重要.
研究的目的:
- 提供基因疗法类型及其独特特征的概述.
- 为基于腺相关病毒 (AAV) 的基因疗法提出先进的MIDD方法.
- 为了解决在基因疗法中更好地选择剂量的需要.
主要方法:
- 对基因疗法类型,生物分析,配方,管理和监管方面的审查.
- 建议整合基于生理学的药物动力学建模和AAV基因疗法的定量系统药理.
- 在剂后对AAV和蛋白动态的整体建模.
主要成果:
- 该审查概述了基因治疗的生物和监管格局.
- 为推进MIDD在AAV基因治疗中提出了一个框架.
- 拟议的模型有助于对AAV药理的深入探索.
结论:
- 先进的MIDD方法,特别是PBPK和QSP,可以告知AAV基因疗法剂量毒性和剂量有效性.
- 拟议的整体建模方法可以指导AAV基因治疗剂量选择.
- 这一策略可能是利用基因疗法治疗未满足需求的疾病的关键.
相关概念视频
Microorganisms in Medicine and Therapeutics
35
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
35
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
In-vitro Mutagenesis
14.0K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.0K


